Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if the combination of the immunotherapy
drugs, CT-011 and rituximab, can help control follicular lymphoma. The safety of this drug
combination will also be studied.